Clopidogrel Bisulfate
40 NDCs across 14 manufacturers|40 Generic,0 Brand
▸ More about this market▾ Less
The brand product was first FDA-approved on Nov 17, 1997, and the first generic was approved Jan 14, 2008. FDA's Orange Book lists 24 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $160 million on Clopidogrel Bisulfate across 13.6 million claims for 3.4 million beneficiaries.
Clopidogrel Bisulfate is available as 40 NDCs from 14 manufacturers (40 generic, 0 brand), with NADAC prices from $0.05 to $5.29 per EA — the most expensive product costs about 112× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
40
40G / 0B
Manufacturers
14
competing in market
Price Spread
$0.05 – $5.29
per EA
7d Activity
avg +0.3% WoW · of 40 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Dr. Reddy's Laboratories Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
P2Y12 Platelet Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
14 manufacturers producing CLOPIDOGREL BISULFATE
Frequently Asked Questions
When did Clopidogrel Bisulfate become available as a generic?
FDA approved the first generic Clopidogrel Bisulfate (ANDA) on Jan 14, 2008. The Orange Book currently lists 24 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Clopidogrel Bisulfate?
In 2024, Medicare Part D spent $160 million on Clopidogrel Bisulfate across 13.6 million claims for 3.4 million beneficiaries.
How many Clopidogrel Bisulfate products are on the market?
The Clopidogrel Bisulfate drug market contains 40 NDCs from 14 manufacturers — 40 generic and 0 brand products.
What is the price range for Clopidogrel Bisulfate?
NADAC reference prices for Clopidogrel Bisulfate range from $0.0472 to $5.2911 per EA — the most expensive product costs about 112× the cheapest.
Which manufacturers make Clopidogrel Bisulfate?
14 manufacturers list Clopidogrel Bisulfate in NADAC. Ranked by number of NDCs, the largest are Dr. Reddy's Laboratories Inc. (7), Aurobindo Pharma Limited (4), Novadoz Pharmaceuticals LLC (4), ScieGen Pharmaceuticals Inc. (4), Westminster Pharmaceuticals LLC (3).
How has the price of Clopidogrel Bisulfate changed recently?
Over the past 7 days, 27 Clopidogrel Bisulfate NDCs rose and 0 fell, with a market-wide average change of +0.3%.